plan
play

Plan Performance Reporting Understanding financial performance, - PowerPoint PPT Presentation

Plan Performance Reporting Understanding financial performance, Forward Risk, and Group Health Status Todays Agenda o PPR description o How to do it o Standalone System? o Resources o Cautions o Examples 2 An analytic process that always


  1. Plan Performance Reporting Understanding financial performance, Forward Risk, and Group Health Status

  2. Today’s Agenda o PPR description o How to do it o Standalone System? o Resources o Cautions o Examples 2

  3. An analytic process that always evaluates: • Group demographics; • Current and historical financial performance; • Utilization and cost of services and drugs; and, • Large Claimants and some aspects of group risk. What is It? An analytic process that sometimes evaluates: • Group health status (may include biometrics); • Quality of care; • A more Comprehensive group risk profile; • Relative plan value and comparison; and, • Third party vendor and/or program performance. 3

  4. How is PPR evolving? Prescriptive Goal Predictive Diagnostic Current Descriptive Typical Health Plan Reporting 4

  5. Depends on corporate culture… How Much • Senior management attention; Does it matter • Data driven planning and decision-making processes; and, to My • High priority for improving Company? employee health and well-being. 5

  6. System and Process Things to Consider 6

  7. Do We Need a Standalone System? Probably Probably Not • Membership > 500 – 750; • Membership < 250 – 500; • Self-insured; • Fully-insured; • Benefits out-to-bid frequently; • Infrequent carrier changes; • Multiple Plan designs; • Few plan designs; • Multiple vendors (health plan, PBM, • Medical and pharmacy benefits with a health management; single health plan; • Large Claimant or cost/quality issues; • Stable membership and plan and, performance; • Limited Plan/vendor reporting. • High quality plan reporting. 7

  8. Why you might want a standalone System… Percent of Current Prior Current YOY Change Total Total Spend $1,373,857 $2,435,308 +77.3% - Total Medical $1,024,057 $1,917,433 +87.2% 78.7% Total Pharmacy $349,801 $517,875 48.0% 21.3% Medical Paid Per Member - $1,894 $2,577 +36.1% 8

  9. If so, Which Which one is less important One? than whether it’s used. ➢ Multiple systems with varying capabilities on the market; ➢ Should select a system that best matches your company and reporting requirements; ➢ Broker assistance required during decision. ➢ Consider BAN informatics partners. 9

  10. Pros: 1. Improved “Why” and “What if” What are capabilities; the Pros 2. Long-term view: Maintains a cross-carrier integrated long-term database; and Cons? 3. Flexibility re: reporting format and schedule. Cons: 1. Learning curve, especially at front-end; 2. Requires dedicated resource (broker- provided and/or internal); 3. Resource requirements and cost increase with number of groups in system. 4. May need clinical resource. 5. Somebody needs to interpret the data and curate reports. 10

  11. What to focus on 1. Providing accurate reliable management reports that are more robust than plan reporting. 2. Identifying root causes of plan performance issues that have practical actionable solutions. 11

  12. Common Mistakes 12

  13. Don’t have an in -house The BIG resource or leader. Ones… Just show eye-candy. Pay relatively less attention to analysis interpretation. 13

  14. Avoid creating a unique report format for each plan, group, or business unit (except for logos). Use standard metrics. Use a common baseline (summary) Over Customization format and add sections required by individual units. Try to “reuse” sections across groups. 14

  15. Data Stuff • Use judgement when evaluating changes in metrics. Just because numbers are different, don’t assume they are significantly different! • Don’t misinterpret random variation (“noise”) as trend. Most of what we call “trend” is actually “change”. • Understand the definitions of “norm” or “benchmark” in plan reports. They are frequently misused (benchmark actually means best observed (not average) performance)and vary from plan to plan. • For efficiencies sake, don’t overanalyze value variances that are not material to plan performance or member health (example: moderately elevated ER Visit rate. 15

  16. Trend- What is it? How Should it be measured? 16

  17. Trend Measurement (Cautions) Yearly Cost Summary $300 $272 $271 $250 $183 $200 The costs in this case $150 are looking at $93 $92 $100 different member $73 $50 populations. Take care when budgeting. $0 Medical Rx 2017 2018 2019 Acme Medical Costs PMPM have been at market and stable over the past two years despite market medical trend being 5% - 8%. Acme Pharmacy Costs PMPM are lower than market and have decreased by 20% since 2018. Market pharmacy trend over that period has been 6% - 10%. Year to Year comparisons are less reliable than usual due to Acme’s rapid increase in membership and short 2019 plan year. 17

  18. Trend Measurement (Cautions) High volatility makes trend Total PMPM estimates unreliable. $600 Early to mid-2018 claims volatility $500 was low. $400 $300 High claims volatility has occurred $200 over 2019. This volatility makes $100 measuring trend from 2018 – $0 2019 unreliable. February-17 April-17 May-17 July-17 September-17 October-17 November-17 December-17 February-18 April-18 May-18 July-18 September-18 October-18 November-18 December-18 February-19 April-19 May-19 January-17 March-17 June-17 August-17 January-18 March-18 June-18 August-18 January-19 March-19 June-19 What are the Implications for: 1. Budgeting; Early to mid-2018 claims volatility was low. Moderate Claims volatility has 2. Fully- Insured Renewals; and, occurred over the last twelve months. We suspect that the cost 3. Stop-loss renewals? spike in early 2019 is related to Large Claimant activity. 18

  19. More on Trend… Medical cost volatility was relatively high. This volatility accounted for the increase in PMPM claims in the first part of 2018. Medical trend (dotted line) was slightly negative over the periods. Pharmacy cost volatility was low. Trend was flat. 19

  20. Examples and Tips: Analyses, and Report Exhibits 20

  21. Demographics What Matters? 21

  22. Relationship- Simple Look Relationship % Members % Paid Avg PMPY Variance Employee 48.0% 41 .7% $5,257 -13% Spouse 1 6.1 % 38.6% $1 4,498 140% Dependent 35.9% 1 9.7% $3,320 -45% Total --- --- $6,050 0% 1 Relationship Total C ost % HC C Employee $2,81 5,925 34.9% Spouse $2,606,588 65.1 % Spousal Surcharge? Dependent $1 ,330,305 31 .5% All Members $6,752,81 8 45.9% 1 % of costs due to High C ost C laimants ("HC C s") Although spouses only accounted for 16.1% of members, they accounted for 38.6% of costs. This disproportionate cost contribution was in large part due to costly spouse HCCs. 22

  23. Age Distribution: Good Plan Analysis Current Percent of Membership, Claimants and Plan Paid Comparison 31% 30% 27% 21% 18% 17% 17% 16% 17% 16% 14% 12% 12% 12% 10% 8% 9% 7% 7% 0% 0% 1% 0% 0% 0 to 19 Males 0 to 19 Females 20 to 44 Males 20 to 44 Females 45 to 64 Males 45 to 64 Females 65/Over Males 65/Over Females % of Members % of Claimants % Plan Paid Chronic Conditions 23

  24. Member Risk and Health Segmentation 24

  25. Summary View

  26. Another Way… Risk Cohorts and PEPM Cost $600 $500 $400 High $303 $300 Moderate $277 Low $200 $186 $100 $0 2015 - 2016 2016 - 2017 2017 - 2018 Costs for High and Moderate Risk cohorts have been stable. Costs for the Low Risk cohort have decreased significantly year over year. 26

  27. Another Way… Avg PMPY C ost C ohort % C laimants % Paid MC Acme Dean Benchmark Variance 72.6% 5.5% $230 4.3% $0 to $999 $240 $1,000 to $1,999 8.6% 3.8% $1 ,356 4.0% $1 ,41 3 4.2% 3.2% $2,391 3.4% $2,000 to $2,999 $2,476 Healthy $3,000 to $3,999 2.6% 2.8% $3,354 3.0% $3,456 $4,000 to $4,999 1 .9% 2.6% $4,380 2.6% $4,498 $5,000 to $9,999 4.2% 9.2% $6,372 9.7% $7,060 C hronic C onditions $1 2,507 $10,000 to $24,999 3.3% 15.5% 17.0% $15,076 $25,000 to $49,999 $28,999 C omplex C hronic C onditions 1.7% 17.9% 14.3% $33,847 $50,000 to $74,999 0.6% 1 0.9% $56,747 8.1 % $61 ,735 $75,000 to $99,999 0.1 % 2.6% $83,271 5.5% $88,085 HC C s $100,000+ $1 39,764 0.4% 25.9% 28.5% $195,488 72.6% of claimants incurred claims <$1,000 in the most recent 12 months. The health status of these members is uncertain. Individuals with chronic, complex chronic, and catastrophic conditions had higher than benchmark costs. This combination of findings suggests that a significant percentage of this cost cohort may be “skipping” preventive care and care for chronic conditions.

  28. Large Claimants: Typical Plan Reporting HCC Only HCC Prior HCC Current YOY Change Number of HCC Claimants 3 3 0% Medical Paid for HCC $234,046 $579,899 147.8% Average Paid per Claimant $78,015.38 $193,299.54 147.8% % of Total Medical Paid 22.9% 30.2% 7.4% Total Medical Net of HCC Net of HCC Prior Net of HCC Current YOY Change Medical Paid Per Member $1,461 $1,798 23.0% Inpatient Paid Per Member $213 $363 70.7% Ambulatory Paid Per Member $1,248 $1,435 14.9% 28

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend